سعر ريميجولين 0.5 مجم 2 قرص 2024

Cabergoline 0.5 mg tablets, pack of 2 tablets, Hochster Pharmaceutical Industries, marketed in Egypt.

• Hyperprolactinaemic disorders, idiopathic or due to pituitary adenomas, in adultsDailyMed (U.S. National Library of Medicine)

• Most common (>10%): nausea, headache and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Uncontrolled hypertension; known hypersensitivity to ergot derivatives.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• History of cardiac valvular disorders or pericardial fibrosis; history of pleural, pulmonary or retroperitoneal fibrotic disorders.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Cardiac valvulopathy and pericardial fibrosis: echocardiographic monitoring every 6-12 months or as clinically indicated.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Pleural, retroperitoneal and pulmonary fibrosis, orthostatic hypotension, impulse control disorders; avoid use for suppression of postpartum lactation.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• D2 antagonists (phenothiazines, butyrophenones, thioxanthenes, metoclopramide)Concomitant use not recommended.DailyMed (U.S. National Library of Medicine)

• If conception occurs, discontinue if risks to mother or fetus outweigh benefits; in general avoid dopamine agonists during pregnancy and the postpartum period.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not recommended in postpartum women who are breastfeeding or planning to breastfeed.International label, same formulation · DailyMed (U.S. National Library of Medicine)